<DOC>
	<DOC>NCT01334684</DOC>
	<brief_summary>Our general aim is to investigate whether messenger RNA (mRNA) and/or microRNA (miRNA) expression profiles in white blood cells, predict metformin monotherapy efficacy in patients with type 2 diabetes.</brief_summary>
	<brief_title>Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes (duration of diabetes of at least 2 years) age 4070 yrs HbA1c &gt; 6.4 &lt; 9.0 insulin therapy contraindications to metformin use</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Metformin Efficacy</keyword>
	<keyword>Gene Expression Profiles</keyword>
	<keyword>Personalized Medicine</keyword>
</DOC>